Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

MYSTERIOUS: 2 - What They Never Told You

GSK boss Emma Walmsley’s pay could rise to nearly £22m in three years’ time

UK pharmaceutical companies aim to put executive pay on par with US rivals’ but package will depend on share price

The Guardian - UK

Women hold almost 45% of seats on FTSE 100 boards, report says

New high tempered by dip in number of female CEOs at 100 biggest listed firms to fewer than 10 last year

The Guardian - UK

Drug firm GSK delivers a syringe full of crowd-pleasers

Pharmaceuticals company’s higher dividend, upgrade to revenues and share buyback suggest its drugs pipeline is flowing nicely

The Guardian - UK

From analysis to the latest developments in health,
read the most diverse news in one place.

GSK lifts long-term sales targets on new drug pipeline

It came as the boss of the London-listed firm cheered an ‘excellent’ performance in 2024.

Evening Standard

FTSE 100 Live 30 October: Next forecasts £1bn profit, GSK vaccine sales weakness hits shares

A £1 billion profits landmark for Next and strong trading at Standard Chartered today provided FTSE 100 cheer during another painful session for GSK investors.

Evening Standard

GSK’s health is improving. Shame about the legal heartburn

Emma Walmsley’s overhaul seems to be delivering the goods even if US worries have left the share price becalmed

The Guardian - UK

GlaxoSmithKline boss’s pay package jumps 50% to £12.7m

Emma Walmsley’s deal, with a high share bonus payout, makes her one of top-paid CEOs in FTSE 100

The Guardian - UK

Read news from The Economist, FT, and more,
with one subscription

Obesity drug boom pushes Novo Nordisk shares to record high

Market value of Danish drugmaker behind Wegovy and Ozempic tops $500bn as demand soars

The Guardian - UK

FTSE 100 bosses ‘given average pay rise of £500,000 in 2022’

CEOs received average increase of 16% while pay of many working for them failed to keep up with inflation

The Guardian - UK

Tech spending: The companies on London’s blue chip index exploring AI

A host of FTSE 100 companies are among businesses planning to invest in AI

Evening Standard

GSK CEO Emma Walmsley says A.I. could improve Big Pharma's most 'profound' challenge: R&D inefficiency

"When we talk about health care costs, the single biggest thing we can do is innovate more.”

Fortune

GSK’s CEO says you need thick skin if you’re going to step into the C-suite

Emma Walmsley reflects on what it takes to lead a company through a turnaround.

Fortune

Why GSK's Emma Walmsley 'violently rejects' the idea of 'superhero' CEOs

In her mind, leadership is about inspiring collaboration.

Fortune

New CBI boss says she is ‘profoundly sorry’ to women let down by group

Rain Newton-Smith’s tweets came on day she became director general at Confederation of British Industry

The Guardian - UK

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

GSK boss warns UK life sciences at ‘tipping point’ despite Sunak’s R&D pledge

Emma Walmsley says ambition to be pharma superpower at risk unless improvements made in key areas

Evening Standard

GSK to move back to central London with new HQ

Six floor office building on New Oxford Street will be workplace for 3,000 staff including CEO

Daily Mirror

Meet Britain's 10 highest paid fat cats who pocketed more than £100m last year

That means they are now getting 109 times more in their wage slips than the typical British worker - up from 79 times in the previous year

Evening Standard

Gender pay gap widens in FTSE100 boardrooms

Emma Walmsley is only woman in top 50 best paid Footsie directors

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

GSK boss upbeat over spin-off of consumer healthcare unit

Expected to be the biggest London listing in a decade, the Haleon demerger is scheduled for July

The Guardian - UK

Noisy activists aside, GSK investors backed Walmsley and her strategy

The ‘step-change’ in growth for the core pharma division has barely started, but the CEO is secure for now

Evening Standard

Under pressure GlaxoSmithKline promises ‘landmark’ year as its outshone by Pfizer

GlaxoSmithKline remained under pressure today after so-so results that drew unfavourable comparisons with US rival Pfizer.

The Guardian - UK

GSK boss pledges ‘landmark year’ as pharma firm pursues demerger

Results better than forecast but Emma Walmsley is under pressure from activist investors clamouring for change

The Guardian - UK

GSK’s top scientist jumps ship in new blow for pharmaceutical firm

Hal Barron to leave just as pressure builds on GSK to come up with new medicines

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.